Recruiting Cystic Fibrosis Studies in Gainesville
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or I...
4D-710 in Adult Patients With Cystic Fibrosis
This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....
About Cystic Fibrosis Clinical Trials in Gainesville
Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.
There are currently 2 cystic fibrosis clinical trials recruiting participants in Gainesville, GEORGIA. These studies are seeking a combined 770 participants. Research is being sponsored by Chris Goss, 4D Molecular Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cystic Fibrosis Clinical Trials in Gainesville — FAQ
Are there cystic fibrosis clinical trials in Gainesville?
Yes, there are 2 cystic fibrosis clinical trials currently recruiting in Gainesville, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Gainesville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.
Are clinical trials in Gainesville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.
What cystic fibrosis treatments are being tested?
The 2 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov